Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes

Mucosal antibodies harboring various antiviral activities may best protect mucosal surfaces against early HIV-1 entry at mucosal sites and they should be ideally induced by prophylactic HIV-1 vaccines for optimal prevention of sexually transmitted HIV-1. A phase I, double-blind, randomized, placebo-...

Descripción completa

Detalles Bibliográficos
Autores principales: Leroux-Roels, Geert, Maes, Cathy, Clement, Frédéric, van Engelenburg, Frank, van den Dobbelsteen, Marieke, Adler, Michael, Amacker, Mario, Lopalco, Lucia, Bomsel, Morgane, Chalifour, Anick, Fleury, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577797/
https://www.ncbi.nlm.nih.gov/pubmed/23437055
http://dx.doi.org/10.1371/journal.pone.0055438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577797/
https://www.ncbi.nlm.nih.gov/pubmed/23437055
http://dx.doi.org/10.1371/journal.pone.0055438

Ejemplares similares